Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium

Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study

(2018) Mary Hobart et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy of adjunctive low-dose cariprazine in major depressive disorder

(2018) Maurizio Fava et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants

(2016) Suresh Durgam et al.   JOURNAL OF CLINICAL PSYCHIATRY

Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants

(2016) Robert M. Berman et al.   CNS SPECTRUMS

Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study

(2015) George I. Papakostas et al.   AMERICAN JOURNAL OF PSYCHIATRY

Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants

(2015) Michael E. Thase et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder

(2015) Michael E. Thase et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)

(2012) Maurizio Fava et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

(2010) Nizar El-Khalili et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Efficacy of Risperidone Augmentation to Antidepressants in the Management of Suicidality in Major Depressive Disorder

(2009) Hollis Reeves et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

(2009) Michael Bauer et al.   JOURNAL OF CLINICAL PSYCHIATRY

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression

(2008) Gabor I. Keitner et al.   JOURNAL OF PSYCHIATRIC RESEARCH